Brief: Achilles Therapeutics Reports Data On Cnet And Significant Increase In Cnet Dose From Velos Process 2 Manufacturing
12/11/2021 12:46
Nov 12 (Reuters) - Achilles Therapeutics PLC 698y.F :
* ACHILLES THERAPEUTICS PRESENTS DATA AT THE SOCIETY FOR
IMMUNOTHERAPY OF CANCER (SITC) ANNUAL MEETING DEMONSTRATING THE
ABILITY TO DETECT, QUANTIFY AND TRACK PATIENT-SPECIFIC CNET AND
SIGNIFICANT INCREASE IN CNET DOSE FROM VELOS™ PROCESS 2
MANUFACTURING
Source text for Eikon: ID:nGNX49Jlx7
Further company coverage: 698y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement